Likewise, for the enzyme inhibition tests, the IC50 values for cholinesterase inhibition (AChE and BCHE) were close to those of the reference compound, galantamine, which served as the positive control since it is clinically applied in the management of mild Alzheimer’s disease. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.